Epidemiology of childhood brain tumours in Yorkshire, UK, 1974-95: geographical distribution and changing patterns of occurrence
1998

Epidemiology of Childhood Brain Tumours in Yorkshire, UK

Sample size: 455 publication Evidence: moderate

Author Information

Author(s): PA McKinney, RC Parslow, SA Lane, CC Bailey, I Lewis, S Picton, RA Cartwright

Primary Institution: University of Leeds

Hypothesis

What are the patterns of occurrence and geographical distribution of childhood brain tumours in Yorkshire from 1974 to 1995?

Conclusion

The study found a rising incidence of all CNS tumours, particularly primitive neuroectodermal tumours, and showed that astrocytomas are occurring at a younger age, likely due to improved diagnostic technology.

Supporting Evidence

  • 455 cases of CNS tumours were analyzed from a high-quality population-based register.
  • There was a significant increase of 1.8% in average annual incidence for all CNS tumours.
  • Astrocytomas occurred more commonly in 0 to 4-year-olds in the most recent time period.
  • Geographical differences in incidence were evident, with lower rates in urbanized areas.
  • Improved diagnostic technology likely contributed to the rising incidence.

Takeaway

This study looked at brain tumours in kids in Yorkshire and found that more kids are getting diagnosed with these tumours, especially a type called PNET, and younger kids are being diagnosed with astrocytomas more often now.

Methodology

The study analyzed data from a population-based register of children with cancer, focusing on cases diagnosed with CNS tumours over a 22-year period.

Potential Biases

There may be risks of bias related to the completeness of case registration and potential underreporting.

Limitations

The study may not account for all potential risk factors due to the ecological nature of the analysis and small numbers of cases at ward level.

Participant Demographics

Children diagnosed with CNS tumours in Yorkshire, UK.

Statistical Information

P-Value

p<0.01 for all CNS tumours; p<0.05 for PNETs

Confidence Interval

95% CI 0.5-3.1 for all CNS tumours; 95% CI 0.1-6.1 for PNETs

Statistical Significance

p<0.05

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication